Zhejiang Haisen Pharmaceutical Co., Ltd. (SHE:001367)

China flag China · Delayed Price · Currency is CNY
20.85
-0.27 (-1.28%)
At close: May 28, 2026
Market Cap3.13B +2.8%
Revenue (ttm)520.97M +9.9%
Net Income133.58M +11.0%
EPS0.88 +10.5%
Shares Out 150.34M
PE Ratio23.68
Forward PEn/a
Dividend0.12 (0.55%)
Ex-Dividend DateMay 13, 2026
Volume1,285,700
Open21.13
Previous Close21.12
Day's Range20.54 - 21.13
52-Week Range19.90 - 28.00
Beta0.20
Analystsn/a
Price Targetn/a
Earnings DateAug 14, 2026

About SHE:001367

Zhejiang Haisen Pharmaceutical Co., Ltd., together with its subsidiaries, engages in the research, development, production, and sale of pharmaceutical intermediates, active pharmaceutical ingredients, and preparations in China and internationally. The company offers active pharmaceutical ingredients for use as antilipemic agents, antipyretic analgesics, antidepressants, analgesics, antibacterial agents, histamine drugs, and anticonvulsants, as well as for anti-gastric ulcers, and digestive and cardiovascular applications. It also provides chemi... [Read more]

Sector Healthcare
Founded 1998
Employees 705
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 001367
Full Company Profile

Financial Performance

In 2025, SHE:001367's revenue was 532.26 million, an increase of 12.88% compared to the previous year's 471.51 million. Earnings were 135.88 million, an increase of 10.87%.

Financial Statements